Evidence map›Paper›PMID 24733118›Full record

ReviewNature reviews. Nephrology2014

Renal denervation--implications for chronic kidney disease.

Roland Veelken, Roland E Schmieder

2 registry-linked trialsAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Nephrology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04264403 nacompletednot on this mapstarted 2020, after this paper: background citation

Effect of Renal Denervation on Blood Pressure in Patients With Chronic Kidney Disease and Uncontrolled Hypertension

TypeinterventionalSponsorUniversity of Erlangen-Nürnberg Medical SchoolRan2020 to 2024Enrolled44ConditionsUncontrolled Hypertension, Renal Denervation, Chronic Kidney Disease stage3ArmsRenal denervation
NCT07742787 naactive not recruitingnot on this mapstarted 2024, after this paper: background citation

Effect of Renal Denervation on Blood Pressure in Patients With Chronic Kidney Disease and Uncontrolled Hypertension

TypeinterventionalSponsorHippocration General HospitalRan2024 to 2027Enrolled20ConditionsUncontrolled Hypertension, Renal Denervation, Chronic Kidney Disease (Stage 3)ArmsRenal denervation, Sham procedure control
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Neuroimmune interplay in kidney health and disease: Role of renal nerves.Autonomic neuroscience : basic & clinical · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Neurogenic tachykinin mechanisms in experimental nephritis of rats.Pflugers Archiv : European journal of physiology · 2020
    Article
  12. Article
  13. Article
  14. Review
  15. Renal denervation and CD161a immune ablation prevent cholinergic hypertension and renal sodium retention.American journal of physiology. Heart and circulatory physiology · 2019
    Article
  16. Article
  17. Renal sympathetic nerve activation via αKidney research and clinical practice · 2019
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Roland VeelkenDepartment of Nephrology and Hypertension, University Hospital, University Erlangen/Nürnberg, Ulmenweg 18, 91054 Erlangen, Germany.
Roland E SchmiederDepartment of Nephrology and Hypertension, University Hospital, University Erlangen/Nürnberg, Ulmenweg 18, 91054 Erlangen, Germany.
Friedrich-Alexander-Universität Erlangen-Nürnberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Catheter-based renal denervation to treat patients with resistant hypertension and chronic kidney disease (CKD) has generated considerable interest. Data from the majority of, but not all, observational studies and randomized controlled trials suggest that the procedure does not impair renal function and can effectively reduce office and ambulatory blood pressure in patients with primary hypertension. The putative beneficial effects of renal denervation seem to result from the interruption of renal efferent and afferent nerves. In patients with resistant hypertension and CKD, interruption of afferent reflexes might lead to a reduction in global sympathetic tone. The subsequent sustained reduction in blood pressure is expected to slow the progression of renal disease. However, renal denervation might also improve glucose metabolism, increase insulin sensitivity and reduce renal inflammation, with renoprotective effects in patients with CKD. Additional large randomized controlled trials of renal denervation in hypertensive and normotensive patients with CKD are required to precisely define the clinical value of the procedure in this population.

Indexed as

Autonomic DenervationHumansKidneyRenal Insufficiency, Chronic

Identifiers

PMID24733118
OpenAlexW1970647993

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.